[1,2,4]triazolo[3,4-b][1,3]benzothiazol-7-ol manufacturers
- OUL245
-
- $1520.00
-
2026-05-11
- CAS:1023814-45-0
- Purity:
- Supply Ability: 10g
|
| | [1,2,4]triazolo[3,4-b][1,3]benzothiazol-7-ol Basic information |
| Product Name: | [1,2,4]triazolo[3,4-b][1,3]benzothiazol-7-ol | | Synonyms: | [1,2,4]triazolo[3,4-b][1,3]benzothiazol-7-ol;1,2,4-Triazolo[3,4-b]benzothiazol-7-ol;OUL245 | | CAS: | 1023814-45-0 | | MF: | C8H5N3OS | | MW: | 191.21 | | EINECS: | | | Product Categories: | | | Mol File: | 1023814-45-0.mol | ![[1,2,4]triazolo[3,4-b][1,3]benzothiazol-7-ol Structure](CAS/20180528/GIF/1023814-45-0.gif) |
| | [1,2,4]triazolo[3,4-b][1,3]benzothiazol-7-ol Chemical Properties |
| Melting point | 284-286 °C | | density | 1.77±0.1 g/cm3(Predicted) | | pka | 7.55±0.30(Predicted) |
| | [1,2,4]triazolo[3,4-b][1,3]benzothiazol-7-ol Usage And Synthesis |
| Uses | OUL245 is a 7-Hydroxy derivative, and a selectively PARP2 inhibitor (IC50=44 nM). OUL245 also inhibits other PARP and TNKS enzymes with IC50s of 2.9-8.8 μM[1]. | | IC 50 | PARP2: 44 nM (IC50); PARP-1: 570 nM (IC50); PARP3: 8.8 μM (IC50); PARP4: 6.0 μM (IC50); TNKS1: 1.6 μM (IC50); TNKS2: 370 μM (IC50); PARP10: 2.9 μM (IC50); PARP14: 6.7 μM (IC50); PARP15: 2.0 μM (IC50) | | References | [1] Murthy S, et al. [1,2,4]Triazolo[3,4-b]benzothiazole Scaffold as Versatile Nicotinamide Mimic Allowing Nanomolar Inhibition of Different PARP Enzymes. J Med Chem. 2023 Jan 4. DOI:10.1021/acs.jmedchem.2c01460 |
| | [1,2,4]triazolo[3,4-b][1,3]benzothiazol-7-ol Preparation Products And Raw materials |
|